OMEROS CORPORATION ANNOUNCES UPCOMING PRESENTATIONS DETAILING OUTCOMES OF NARSOPLIMAB TREATMENT FOR TA-TMA UNDER AN EXPANDED ACCESS PROGRAM
Source text: ID:nBwjyysfa
Further company coverage: OMER.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.